← Back to Search

AR Tool for Post-Surgery Symptoms in Pediatric Cancer Patients

N/A

Recruiting

Led By Juan Cata, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Surgery with an estimated duration longer than 2 hours

Current diagnosis of pediatric cancer or benign neoplasm

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial tests if a tool can measure pain, nausea, and vomiting in Hispanic kids with cancer after surgery.

Who is the study for?

This trial is for English or Spanish-speaking kids aged 7-17 with cancer who are having surgery lasting over 2 hours and will need painkillers like opioids after. They must be able to understand and use the game in the study, and have a guardian's consent. Kids can't join if their doctor thinks the app isn't right for them or if parents don't agree.

What is being tested?

The study is testing how well an electronic tool works when used by kids recovering from cancer surgery to report their pain, nausea, and vomiting. It uses augmented reality (AR) technology to help measure these postoperative conditions.

What are the potential side effects?

Since this trial involves using an electronic assessment tool rather than a medication, there aren't typical drug side effects. However, discomfort or frustration with using the AR tool could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My surgery is expected to last more than 2 hours.

Select...

I am currently diagnosed with cancer or a non-cancerous tumor as a child.

Select...

I can agree to participate, and my legal guardian can give informed consent for me.

Select...

I am between 7 and 17 years old.

Select...

I will be prescribed opioids after surgery while in the hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Augmented reality (AR)Experimental Treatment1 Intervention

Augmented reality (AR) Participants will view the real world through a device's camera and application ("app") but adds virtual or digital characters and items to the image

0 / 5Eligibility criteria met